article Open AccessTop 1% cited
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Annals of Oncology · 2016 · Vol. 27(8) · pp. 1386–1422
Eric Van Cutsem✉(KU Leuven)Andrés Cervantes(INCLIVA Health Research Institute)René Adam(Hôpital Paul-Brousse)Alberto Sobrero(Ospedale Policlinico San Martino)J. Han van Krieken(Radboud University Nijmegen)Dan Aderka(Tel Aviv University)Enrique Aranda(Hospital Universitario Reina Sofía)Alberto Bardelli(University of Turin)Al B. Benson(Northwestern Medicine)G. Bodoky(Unified Szent István and Szent László Hospital)Fortunato Ciardiello(University of Naples Federico II)André D’Hoore(KU Leuven)Eduardo Díaz‐Rubio(Hospital Clínico San Carlos)Jean‐Yves Douillard(Institut de Cancérologie de l'Ouest)Michel Ducreux(Université Paris-Saclay)Alfredo Falcone(University of Pisa)Axel Grothey(WinnMed)Thomas Gruenberger(Rudolfinerhaus Hospital)Karin Haustermans(KU Leuven)Volker HeinemannPaulo M. Hoff(Instituto do Câncer do Estado de São Paulo)C.-H. Köhne(Klinikum Oldenburg)Roberto Labianca(Ospedale Papa Giovanni XXIII)Pierre Laurent‐Puig(Hôpital Européen Georges-Pompidou)Brigette Ma(Chinese University of Hong Kong)Tim Maughan(CRUK/MRC Oxford Institute for Radiation Oncology)Kei Muro(Aichi Cancer Center)Nicola Normanno(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")Pia Österlund(Helsinki University Hospital)Wim J.G. Oyen(Institute of Cancer Research)Demetris Papamichael(Bank of Cyprus Oncology Center)George Pentheroudakis(University of Ioannina)Per Pfeiffer(Odense University Hospital)Timothy Price(Queen Elizabeth Hospital)Cornelis J.A. Punt(University of Amsterdam)Jens Ricke(University Hospital Magdeburg)A. RothRamón Salazar(Institut Català d'Ornitologia)Werner Scheithauer(Medical University of Vienna)Hans‐Joachim Schmoll(Martin Luther University Halle-Wittenberg)Josep Tabernero(Vall d'Hebron Hospital Universitari)Julien Taı̈eb(Hôpital Européen Georges-Pompidou)Sabine Tejpar(KU Leuven)Harpreet Wasan(Hammersmith Hospital)Takayuki Yoshino(National Cancer Center Hospital East)Aziz Zaanan(Hôpital Européen Georges-Pompidou)Dirk Arnold
Colorectal Cancer Treatments and StudiesHepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Surgical TreatmentsMedicineColorectal cancerSystemic therapyDiseaseOncologyIntensive care medicineInternal medicineMultidisciplinary approachCancer
MeSH terms
HumansNeoplasm MetastasisPrognosisBiomarkers, TumorColorectal NeoplasmsGuidelines as TopicMolecular Targeted Therapy
Citations
3,389
FWCI
138.22
field-weighted impact
References
325
Percentile
100%
vs. same field & year
Citations per year
Cited by
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
Journal of Clinical Oncology · 2018 · 2,023 citations
Gut microbiome and its role in colorectal cancer
BMC Cancer · 2021 · 345 citations
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2017 · 2,011 citations
Colorectal cancer liver metastases – a population-based study on incidence, management and survival
BMC Cancer · 2018 · 864 citations
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology · 2017 · 819 citations
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2022 · 1,496 citations
References
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
International Journal of Cancer · 2014 · 28,948 citations
The consensus molecular subtypes of colorectal cancer
Nature Medicine · 2015 · 5,121 citations
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
New England Journal of Medicine · 2015 · 9,308 citations
Cell-free nucleic acids as biomarkers in cancer patients
Nature reviews. Cancer · 2011 · 2,859 citations
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology · 2012 · 1,518 citations
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine · 2014 · 2,220 citations
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2014 · 1,720 citations
Liquid Biopsies: Genotyping Circulating Tumor DNA
Journal of Clinical Oncology · 2014 · 2,169 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.